Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion up front, the company said Thursday, as momentum grows for using versions of the drugs as mental health treatments.